Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The LIPid Intensive Drug Therapy for Sepsis ¬Pilot (LIPIDS-P) Phase I/II Trial

NCT03405870 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT03405870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The LIPid Intensive Drug Therapy for Sepsis ¬Pilot (LIPIDS-P) Phase I/II Trial
Lead sponsor
University of Florida
Phase
Phase 1/2
Overall status
Completed
Start date
August 17, 2018
Completion date
April 26, 2023
Enrollment
59 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, severe, septic shock